| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2011 | EP2276469A2 Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
| 01/26/2011 | EP2276467A2 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/26/2011 | EP2276465A2 Extended release forumulation containing a wax |
| 01/26/2011 | EP2276464A2 Combinations of antiviral agents and other compounds |
| 01/26/2011 | EP2276463A2 Diterpene glycosides as natural solubilizers |
| 01/26/2011 | EP2276460A2 Device for in situ production and topical administration of allicin |
| 01/26/2011 | EP2276459A2 Sulindac formulations in a biodegradable material |
| 01/26/2011 | EP2276455A2 Use of k1f13a and ap-1 inhibitors for inhibiting melanogenesis |
| 01/26/2011 | EP2276347A1 Toltrazuril with improved dissolution properties |
| 01/26/2011 | EP2276346A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
| 01/26/2011 | EP2276345A1 Small-molecule inhibitors of the androgen receptor |
| 01/26/2011 | EP2276344A1 Methods for reducing lipid absorption by an animal |
| 01/26/2011 | EP2276342A1 Substituted tetracycline compounds |
| 01/26/2011 | EP2203439B1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 01/26/2011 | EP2155740B1 Hetarylanilines as modulators for amyloid beta |
| 01/26/2011 | EP2144597B1 Oil-in-water emulsions ii which stabilize their active ingredient |
| 01/26/2011 | EP2125804B1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 01/26/2011 | EP2125773B1 Thiophene derivatives useful as medicaments for treating ocular hypertension |
| 01/26/2011 | EP2114903B1 Bicyclic pyrimidinones and uses thereof |
| 01/26/2011 | EP2094694B1 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
| 01/26/2011 | EP2094663B1 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 01/26/2011 | EP2089361B1 Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 01/26/2011 | EP2086537B1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 01/26/2011 | EP2081907B1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 01/26/2011 | EP2068825B1 Controlled release delivery system for nasal application of neurotransmitters |
| 01/26/2011 | EP2063710B1 Difluorinated piperidines for treatment of alzheimer's disease and related conditions |
| 01/26/2011 | EP2049515B1 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis |
| 01/26/2011 | EP2049514B1 Nitrate esters of piperidines |
| 01/26/2011 | EP2044029B1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 01/26/2011 | EP2034834B1 Prodrugs of 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione |
| 01/26/2011 | EP2026815B1 Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| 01/26/2011 | EP2019825B9 Inhibitors of human immunodeficiency virus replication |
| 01/26/2011 | EP2004597B1 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 01/26/2011 | EP2004156B1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/26/2011 | EP1957444B1 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use |
| 01/26/2011 | EP1948616B1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 01/26/2011 | EP1919898B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/26/2011 | EP1915150B1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 01/26/2011 | EP1913014B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/26/2011 | EP1904029B1 Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin |
| 01/26/2011 | EP1861402B1 Isoflavonoid dimers |
| 01/26/2011 | EP1856061B1 Tetrahydro- and dihydroquinazolinones |
| 01/26/2011 | EP1853596B1 Novel, long-acting betamimetics for treating respiratory diseases |
| 01/26/2011 | EP1849795B1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 01/26/2011 | EP1842066B1 Biologically active silver-coated proteins |
| 01/26/2011 | EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 01/26/2011 | EP1828221B1 Pure rocuronium bromide |
| 01/26/2011 | EP1786819B1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 01/26/2011 | EP1742645B1 Compressed pharmaceutical compositions comprising peg and electrolytes |
| 01/26/2011 | EP1697377B1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/26/2011 | EP1675833B1 1h-imidazole derivatives as cannabinoid receptor modulators |
| 01/26/2011 | EP1638936B1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/26/2011 | EP1633733B1 Cannabinoid derivatives, methods of making, and use thereof |
| 01/26/2011 | EP1620063B1 Keratolytic composition with anti-allergic and anti-inflammatory properties |
| 01/26/2011 | EP1581490B1 Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides |
| 01/26/2011 | EP1572660B1 Isoquinolinone derivatives and their use as therapeutic agents |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1480941B1 Urea derivatives as hiv aspartyl protease inhibitors |
| 01/26/2011 | EP1446382B1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1365769B1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 01/26/2011 | EP1143925B2 Topical composition comprising n-acetylglucosamine |
| 01/26/2011 | CN201720025U Mixing equipment for preparation process of cooling oil plant medicine combination |
| 01/26/2011 | CN201719685U Beriberi treatment appliance |
| 01/26/2011 | CN201719570U Enriched plaster patch used for treating low fever caused by frightening |
| 01/26/2011 | CN201719419U Novel medicated rib external fixation plaster patch |
| 01/26/2011 | CN1947721B Method for preparing epirubicin slow-release prepn |
| 01/26/2011 | CN1939292B Oral medicinal preparation and oral slow-releasing preparation |
| 01/26/2011 | CN1927861B Garcinia acid derivatives, preparation method and application thereof in pharmacy |
| 01/26/2011 | CN1925853B Stable injectable composition of alpha tocopheryl succinate, and its analogues and salts thereof |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1872063B Microspheres or composition in use for long acting injection of Nalmefene or its salt, and preparation method |
| 01/26/2011 | CN1829521B Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 01/26/2011 | CN1820744B Oseltamivir phosphate granula and its preparing method |
| 01/26/2011 | CN1796388B Sesamin/episesamin compositions |
| 01/26/2011 | CN1713888B Cream for treatment of skin injured by the sun |
| 01/26/2011 | CN101960009A Cationic siRNAs, synthesis and use for interfering RNA |
| 01/26/2011 | CN101959899A New compound derived from germinated brown rice, and agent containing said compound as an active ingredient for prevention or amelioration of neuropathy |
| 01/26/2011 | CN101959896A Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 01/26/2011 | CN101959893A Substituted arylamide oxazepinopyrimidone derivatives |
| 01/26/2011 | CN101959890A Pyrrolopyrimidinecarboxamides |
| 01/26/2011 | CN101959889A Heterocyclic compounds as inhibitors of CXCR2 |
| 01/26/2011 | CN101959888A Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes |
| 01/26/2011 | CN101959887A Pyrrolopyridines as kinase inhibitors |
| 01/26/2011 | CN101959886A Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 01/26/2011 | CN101959885A Derivatives of N-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959884A Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959883A 3-indazolyl-4-pyridylisothiazoles |
| 01/26/2011 | CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound |
| 01/26/2011 | CN101959881A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use |
| 01/26/2011 | CN101959879A 5-oxo-2, 3,4,5-tetrahydro-benzo[B]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[B]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
| 01/26/2011 | CN101959878A Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 01/26/2011 | CN101959877A Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/26/2011 | CN101959876A 2-aminoquinolines |
| 01/26/2011 | CN101959873A 5-hydroxy-2-methyl-4H-pyran-4-one-esters as novel tyrosinase inhibitors |
| 01/26/2011 | CN101959868A Fibrosis inhibitor |
| 01/26/2011 | CN101959866A Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression MCP-1 and CX3CR1 |
| 01/26/2011 | CN101959865A Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 01/26/2011 | CN101959864A 2-aminoquinoline derivatives |
| 01/26/2011 | CN101959861A Trpa1 antagonists |